Serum alpha-fetoprotein levels in neonatal cholestasis

Alpha-fetoprotein (AFP) is used as a tumor marker for hepatocellular carcinoma, hepatoblastoma and germ cell tumors. It may also be elevated in infants with some hepatobiliary disorders. The mechanism of AFP elevation in neonatal cholestasis is not known. We retrospectively evaluated serum AF...

Full description

Saved in:
Bibliographic Details
Main Authors: Hülya Demir, Gülin Hızal, Nuray Uslu Kızılkan, Figen Gürakan, Beril Talim, Turgay Coşkun, Gülsev Kale, Aysel Yüce
Format: Article
Language:English
Published: Hacettepe University Institute of Child Health 2013-04-01
Series:The Turkish Journal of Pediatrics
Online Access:https://turkjpediatr.org/article/view/1473
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849705867526537216
author Hülya Demir
Gülin Hızal
Nuray Uslu Kızılkan
Figen Gürakan
Beril Talim
Turgay Coşkun
Gülsev Kale
Aysel Yüce
author_facet Hülya Demir
Gülin Hızal
Nuray Uslu Kızılkan
Figen Gürakan
Beril Talim
Turgay Coşkun
Gülsev Kale
Aysel Yüce
author_sort Hülya Demir
collection DOAJ
description Alpha-fetoprotein (AFP) is used as a tumor marker for hepatocellular carcinoma, hepatoblastoma and germ cell tumors. It may also be elevated in infants with some hepatobiliary disorders. The mechanism of AFP elevation in neonatal cholestasis is not known. We retrospectively evaluated serum AFP levels in 53 infants with neonatal cholestasis. Thirty patients (56.6%) had elevated AFP, and the ratio of patients with elevated AFP was significantly high in both the metabolic diseases and idiopathic neonatal hepatitis groups (p=0.021). Serum aspartate aminotransferase (AST) levels increased significantly in patients with elevated AFP (p=0.004). Steatosis was the distinctive histopathological finding of the patients with high AFP. The patients with steatosis had significantly higher standard deviation (SD) score of AFP than the patients without steatosis (p=0.001). We have shown AFP elevation in neonatal cholestasis due to metabolic disorders and idiopathic neonatal hepatitis and its association with steatosis and AST elevation.
format Article
id doaj-art-a5d87c521f724d2f8b4c8e5e0ece5a62
institution DOAJ
issn 0041-4301
2791-6421
language English
publishDate 2013-04-01
publisher Hacettepe University Institute of Child Health
record_format Article
series The Turkish Journal of Pediatrics
spelling doaj-art-a5d87c521f724d2f8b4c8e5e0ece5a622025-08-20T03:16:22ZengHacettepe University Institute of Child HealthThe Turkish Journal of Pediatrics0041-43012791-64212013-04-01552Serum alpha-fetoprotein levels in neonatal cholestasisHülya Demir0Gülin HızalNuray Uslu KızılkanFigen GürakanBeril TalimTurgay CoşkunGülsev KaleAysel YüceDivision of Pediatric Gastroenterology, Hacettepe University Faculty of Medicine, Ankara, Turkey. hudemir@hacettepe.edu.tr. Alpha-fetoprotein (AFP) is used as a tumor marker for hepatocellular carcinoma, hepatoblastoma and germ cell tumors. It may also be elevated in infants with some hepatobiliary disorders. The mechanism of AFP elevation in neonatal cholestasis is not known. We retrospectively evaluated serum AFP levels in 53 infants with neonatal cholestasis. Thirty patients (56.6%) had elevated AFP, and the ratio of patients with elevated AFP was significantly high in both the metabolic diseases and idiopathic neonatal hepatitis groups (p=0.021). Serum aspartate aminotransferase (AST) levels increased significantly in patients with elevated AFP (p=0.004). Steatosis was the distinctive histopathological finding of the patients with high AFP. The patients with steatosis had significantly higher standard deviation (SD) score of AFP than the patients without steatosis (p=0.001). We have shown AFP elevation in neonatal cholestasis due to metabolic disorders and idiopathic neonatal hepatitis and its association with steatosis and AST elevation. https://turkjpediatr.org/article/view/1473
spellingShingle Hülya Demir
Gülin Hızal
Nuray Uslu Kızılkan
Figen Gürakan
Beril Talim
Turgay Coşkun
Gülsev Kale
Aysel Yüce
Serum alpha-fetoprotein levels in neonatal cholestasis
The Turkish Journal of Pediatrics
title Serum alpha-fetoprotein levels in neonatal cholestasis
title_full Serum alpha-fetoprotein levels in neonatal cholestasis
title_fullStr Serum alpha-fetoprotein levels in neonatal cholestasis
title_full_unstemmed Serum alpha-fetoprotein levels in neonatal cholestasis
title_short Serum alpha-fetoprotein levels in neonatal cholestasis
title_sort serum alpha fetoprotein levels in neonatal cholestasis
url https://turkjpediatr.org/article/view/1473
work_keys_str_mv AT hulyademir serumalphafetoproteinlevelsinneonatalcholestasis
AT gulinhızal serumalphafetoproteinlevelsinneonatalcholestasis
AT nurayuslukızılkan serumalphafetoproteinlevelsinneonatalcholestasis
AT figengurakan serumalphafetoproteinlevelsinneonatalcholestasis
AT beriltalim serumalphafetoproteinlevelsinneonatalcholestasis
AT turgaycoskun serumalphafetoproteinlevelsinneonatalcholestasis
AT gulsevkale serumalphafetoproteinlevelsinneonatalcholestasis
AT ayselyuce serumalphafetoproteinlevelsinneonatalcholestasis